ResMed investors convert all 4% convertibles

By Jennifer Chiou

New York, March 6 - ResMed Inc. announced holders of all $113.25 million of its 4% convertible subordinated notes due June 20 converted their securities ahead of its call, according to an 8-K filing with the Securities and Exchange Commission.

The company issued 3,737,593 shares as a result of the conversions.

Investors converted their holdings between Jan. 10 and 5 p.m. ET on March 2 into ResMed shares at a conversion price of $30.30 per share. The company's stock closed down $0.43, or 1.08%, at $39.56 on Monday.

The redemption price would have been $1,016 per $1,000 principal amount of notes, including accrued interest through the early redemption date of March 3.

For information on the conversion or redemption, contact American Stock Transfer Shareholder Services at (800) 937-5449.

Based in Poway, Calif., ResMed manufactures medical equipment for the treatment and management of respiratory disorders. The company announced the redemption on Jan. 5.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.